Lineage Cell Therapeutics... (LCTX)
AMEX: LCTX
· Real-Time Price · USD
1.19
0.17 (16.67%)
At close: Aug 15, 2025, 3:59 PM
1.20
0.84%
After-hours: Aug 15, 2025, 07:57 PM EDT
Lineage Cell Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -40.91M | -16.21M | -18.61M | -20.11M | -24.23M | -23.68M | -21.54M | -23.13M | -22.09M | -23.66M | -26.35M | -49.18M | -50.9M | -48.91M | -43.27M | -12.04M | -11.97M | -13.71M |
Depreciation & Amortization | 627K | 598K | 609K | 633K | 668K | 696K | 692K | 690K | 707K | 716K | 727K | 745K | 751K | 769K | 873K | 1.02M | 1.27M | 1.61M |
Stock-Based Compensation | 5.1M | 5.13M | 5.08M | 4.82M | 4.76M | 4.77M | 4.64M | 4.54M | 4.26M | 4.21M | 4.29M | 4.25M | 4.4M | 4.09M | 3.52M | 3.1M | 2.45M | 2.14M |
Other Working Capital | 102K | -175K | -611K | 187K | -3.52M | -6.03M | -7.97M | 60.1M | 59.22M | 57.55M | 87.64M | 21.24M | 22.67M | 27.84M | 642K | 1.21M | 779K | 497K |
Other Non-Cash Items | 13.87M | -9.36M | -7.15M | -6.33M | -198K | -669K | -920K | -464K | 51K | 3.2M | 3.69M | 3.68M | 5.29M | 2.43M | 1.95M | -4.56M | -5.38M | -5.49M |
Deferred Income Tax | n/a | n/a | n/a | -554K | 387K | 1.08M | -720K | -166K | -1.11M | -1.8M | n/a | 1.18M | 169K | -2.17M | -7.74M | -9.98M | -9.15M | -6.16M |
Change in Working Capital | -1.25M | -2.36M | -3.02M | -1.23M | -3.4M | -5.31M | -10.72M | -12.32M | -13.12M | -14.75M | 18.7M | 42.82M | 44.41M | 49.56M | 21.11M | -869K | -553K | -558K |
Operating Cash Flow | -22.56M | -22.2M | -23.09M | -22.77M | -22.02M | -23.11M | -28.57M | -30.85M | -31.29M | -32.09M | 1.06M | 3.49M | 4.12M | 5.77M | -23.56M | -23.33M | -23.33M | -22.15M |
Capital Expenditures | -374K | -424K | -365K | -91K | -318K | -524K | -674K | -567K | -714K | -555K | -413K | -575K | -357K | -389K | -354K | -232K | -188K | -65K |
Cash Acquisitions | n/a | n/a | n/a | n/a | -2.26M | -21.68M | -21.49M | -62.12M | -59.85M | -40.44M | -40.63M | -10.09M | -10.09M | -10.07M | 14K | 11.02M | 11.23M | 17.93M |
Purchase of Investments | n/a | -8.76M | -8.76M | -8.76M | -12.53M | -8.69M | -16.4M | -29.19M | -66.05M | -61.13M | -53.41M | -40.63M | n/a | n/a | -10.07M | 6.61M | 6.41M | -293K |
Sales Maturities Of Investments | 9M | 9.02M | 7.02M | 13.85M | 15.88M | 40.19M | 63.53M | 61.36M | 55.33M | 31M | 7.67M | -6.02M | -6.02M | -6.02M | -12.05M | -22.72M | -22.51M | -15.8M |
Other Investing Acitivies | -214K | -200K | -200K | -200K | 2.26M | 21.68M | 21.49M | 62.12M | 19.23M | -188K | -46K | -24.57M | 16.06M | 16.08M | 22.15M | 6.06M | 6.03M | 6.02M |
Investing Cash Flow | 8.41M | -367K | -2.31M | 4.8M | 3.03M | 30.98M | 46.45M | 31.61M | -11.43M | -30.69M | -46.16M | -41.2M | -357K | -375K | 9.74M | 10.79M | 11.04M | 17.86M |
Debt Repayment | -41K | -55K | -54K | -53K | -52K | -54K | -54K | -50K | -46K | -37K | -32K | -30K | -22K | -15K | -7K | -2K | -9K | 505K |
Common Stock Repurchased | n/a | n/a | -23K | -222K | -222K | -222K | -236K | -20K | -20K | -29K | n/a | -30K | -44K | -49K | -54K | -49K | -41K | -38K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -971K | -1.89M | -1.89M | -1.89M | -921K | n/a | n/a |
Other Financial Acitivies | -380K | 13K | 48K | 305K | 288K | 57K | 88K | 20K | 1.01M | 1.2M | 1.53M | 2.25M | 5.93M | 9.25M | 9.97M | 8.82M | 28.74M | 25.37M |
Financial Cash Flow | 26.47M | 26.88M | 35.86M | 14.11M | 14.92M | 20.44M | 6.42M | 6.56M | 6.71M | 1.12M | 1.63M | 2.46M | 5.22M | 16.48M | 36.93M | 40.79M | 61.63M | 50.84M |
Net Cash Flow | 12.61M | 4.22M | 10.37M | -3.69M | -4.27M | 28.11M | 24.06M | 6.7M | -36.91M | -62.59M | -44.34M | -36.03M | 8.85M | 21.89M | 23.09M | 28.19M | 49.27M | 46.33M |
Free Cash Flow | -22.84M | -22.52M | -23.46M | -22.86M | -22.33M | -23.63M | -29.24M | -31.42M | -32.01M | -32.64M | 646K | 2.91M | 3.76M | 5.38M | -23.91M | -23.56M | -23.52M | -22.22M |